Rates of new cancer cases in the United States have fallen slightly in recent years, according to a new report from the Centers for Disease Control and Prevention.
Rates of new cancer cases in the United States have fallen slightly in recent years, according to a new report from the Centers for Disease Control and Prevention.
Between 2009 and 2010, the rate of invasive cancer in the country dropped from 459 new cases per 100,000 people, to 446 new cases per 100,000 people, the report found. Invasive cancers are those that have spread beyond their site of origin into the surrounding tissue.
Rates were higher among men than women (503 new cases per 100,000 people for men compared to 405 new cases per 100,000 people for women), according to the report.
The most common invasive cancers were prostate cancer, breast cancer in women, lung and bronchus cancer, and colon and rectum cancers, which all together make up about half of U.S. cancer cases, the CDC said.
Read the full story here:
Source: Huffington Post
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
FDA Approves Tislelizumab for Advanced or Metastatic ESCC After Chemotherapy
March 15th 2024The FDA has approved tislelizumab-jsgr (Tevimbra) for single-agent use in adult patients with unresectable or metastatic esophageal squamous cell carcinoma following prior systemic chemotherapy that did not include a PD-1/PD-L1 inhibitor.
Read More